University of Maryland School of Medicine - Center for Vaccine Development - Baltimore is a clinical research site located in Baltimore, Maryland, United States 21201-1509.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore has participated in 27 clinical trials.
Therapeutic areas: COVID-19, Influenza, Tularaemia.
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore has 27 clinical trials on record. Their work covers COVID-19, Influenza, Tularaemia.
Yes — University of Maryland School of Medicine - Center for Vaccine Development - Baltimore holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.